(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE ROLUPERIDONA NA PREVENÇÃO DA RECIDIVA EM PACIENTES COM ESQUIZOFRENIA

Em AnáliseInvention PatentPCT · US2023062500

Application data

Invention Patent USO DE ROLUPERIDONA NA PREVENÇÃO DA RECIDIVA EM PACIENTES COM ESQUIZOFRENIA de MINERVA NEUROSCIENCES, INC. — IPC A61K 31/454
Invention Patent USO DE ROLUPERIDONA NA PREVENÇÃO DA RECIDIVA EM PACIENTES COM ESQUIZOFRENIA de MINERVA NEUROSCIENCES, INC. — IPC A61K 31/454. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024016509

Type

Invention Patent

Filing

02/13/2023

Publication

12/03/2024

PCT

US2023062500

Progress at the INPI

  1. Filing02/13/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 02/13/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/03/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

MINERVA NEUROSCIENCES, INC.

US

Inventors

R. L. (pessoa física)

CH

Technical data

IPC Classification

Priority claims

US

63/309,874 · 02/14/2022

Abstract

USO DE ROLUPERIDONA NA PREVENÇÃO DA RECIDIVA EM PACIENTES COM ESQUIZOFRENIA. Este pedido refere-se a métodos de prevenção da recidiva em pacientes com esquizofrenia que incluem a administração de uma quantidade terapeuticamente eficaz de Roluperidona ao paciente com esquizofrenia.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/03/2024

RPI 2813

Alteração de dados cadastrais

#1.1

08/20/2024

RPI 2798

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.